Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis at the ECTRIMS Annual Congress
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis at the ECTRIMS Annual Congress
Tiziana宣佈在ECTRIMS年會上公佈非活動性繼發性進行性多發性硬化症患者鼻內福拉魯單抗的六個月安全性和生物標誌物數據
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis at the ECTRIMS Annual Congress
Tiziana宣佈在ECTRIMS年會上公佈非活動性繼發性進行性多發性硬化症患者鼻內福拉魯單抗的六個月安全性和生物標誌物數據
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。